McClung David 4
4 · BioCardia, Inc. · Filed Apr 18, 2022
Insider Transaction Report
Form 4
BioCardia, Inc.BCDA;BCDAW
McClung David
Chief Financial Officer
Transactions
- Award
Common Stock
2022-04-14+50,345→ 97,150 total - Award
Stock Option (right to buy)
2022-04-14+60,000→ 60,000 totalExercise: $1.49Exp: 2032-04-14→ Common Stock (60,000 underlying)
Footnotes (2)
- [F1]The reported securities are represented by restricted stock units ("RSUs"), each of which represents a contingent right to receive one share of the Issuer's common stock. 100% of the RSUs vested on April 14, 2022.
- [F2]The option vests and becomes exercisable as to 1/48th of the shares on May 14, 2022, and each month thereafter, subject to the Reporting Person continuing as a service provider through such date.